Form 4: Bioventus Inc. SVP & CFO Mark Leonard Singleton Reports Stock Transaction

Mark Leonard Singleton, SVP & CFO of Bioventus Inc., reports the disposition of 20,153 shares of Class A Common Stock to satisfy vesting requirements of restricted stock units.

Summary

• On February 15, 2025, Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., disposed of 20,153 shares of Class A Common Stock.
• This transaction was related to the vesting of restricted stock units (RSUs).
• Following the transaction, Singleton directly owns 125,315 shares of Class A Common Stock.
• He also directly owns 60,457 derivative securities in the form of Restricted Stock Units.
• The RSUs vest in four approximately equal installments on each of the first four anniversaries of February 15, 2024, subject to continued service.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a standard transaction related to executive compensation.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the vesting of previously granted equity compensation.

Stakeholder Impact

• The transaction has a minimal direct impact on shareholders as it relates to the vesting of existing equity compensation.

Key Dates

Keywords

Form 4, Bioventus Inc., BVS, Mark Leonard Singleton, SVP & CFO, Stock Transaction, Restricted Stock Units, Class A Common Stock, Beneficial Ownership